ROLE OF BIOLOGICAL THERAPY IN ROTATOR CUFF TENDINOPATHY. EFFECTIVENESS OF PLASMA RICH IN GROWTH FACTOR (PRGF-ENDORET)REGARDING TO FUNCTIONAL CAPACITY AND PAIN COMPARED WITH THE CONVENTIONAL TREATMENT USING STEROIDS

FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS0 个研究点目标入组 84 人2013年8月14日

概览

阶段: 1 期
干预措施: 未指定
疾病 / 适应症: 未指定
发起方: FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS
入组人数: 84
状态: 进行中（未招募）
最后更新: 7年前

暂无简介。

注册库

who.int

开始日期

2013年8月14日

结束日期

待定

最后更新

7年前

研究类型

Interventional clinical trial of medicinal product

发起方

FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS

•Patients between 40 and 70 years old
•Male and female
•Mild to severe symptoms according to the QuickDASH scale over 3 months of evolution.
•Patients with tendinitis, inflammatory or calcium, tendinosis or partial tears of the rotator cuff, diagnosed by ultrasound, evaluated by an expert radiologist independent of the research team.
•Patients refractory to the conservative treatment.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1\.2 Adults (18\-64 years) yes
•F.1\.2\.1 Number of subjects for this age range 42
•F.1\.3 Elderly (\>\=65 years) yes

•Patients with complete tear of the rotator cuff diagnosed by ultrasound or MRI.
•Patients who have previously received treatment with corticoids infiltrations in the last 6 months.
•Patients with arterial hypertension or diabetes mellitus poorly controlled.
•Patients allergic to some of the medicines in the study or some of their excipients.
•Patients treated with anticoagulants or antiplatelet that could not be stopped temporarily for the study.
•Inability to understand health questionnaires and / or complete them properly.
•Patients uncapable to give informed consent.
•Fertile women that do not have a negative pregnancy test before being included in the study.
•Breastfeeding women.